David M. Harlan

19.9k total citations · 8 hit papers
158 papers, 14.0k citations indexed

About

David M. Harlan is a scholar working on Surgery, Genetics and Endocrinology, Diabetes and Metabolism. According to data from OpenAlex, David M. Harlan has authored 158 papers receiving a total of 14.0k indexed citations (citations by other indexed papers that have themselves been cited), including 90 papers in Surgery, 70 papers in Genetics and 63 papers in Endocrinology, Diabetes and Metabolism. Recurrent topics in David M. Harlan's work include Pancreatic function and diabetes (80 papers), Diabetes and associated disorders (67 papers) and Diabetes Management and Research (50 papers). David M. Harlan is often cited by papers focused on Pancreatic function and diabetes (80 papers), Diabetes and associated disorders (67 papers) and Diabetes Management and Research (50 papers). David M. Harlan collaborates with scholars based in United States, Switzerland and Canada. David M. Harlan's co-authors include Allan D. Kirk, Richard M. Bergenstal, Michaël Pollak, Judith G. Regensteiner, Michael C. Archer, Edward L. Giovannucci, Laurel A. Habel, Susan M. Gapstur, Douglas Yee and Kristina I. Rother and has published in prestigious journals such as Science, New England Journal of Medicine and Proceedings of the National Academy of Sciences.

In The Last Decade

David M. Harlan

155 papers receiving 13.7k citations

Hit Papers

Diabetes and Cancer 1997 2026 2006 2016 2010 2002 2010 1997 1999 500 1000 1.5k

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
David M. Harlan United States 52 6.3k 4.3k 4.3k 4.0k 3.8k 158 14.0k
Ali Naji United States 59 6.8k 1.1× 4.6k 1.1× 3.3k 0.8× 3.1k 0.8× 3.8k 1.0× 346 13.0k
Norman M. Kneteman Canada 54 10.6k 1.7× 4.8k 1.1× 4.3k 1.0× 2.9k 0.7× 1.0k 0.3× 209 16.3k
Thierry Berney Switzerland 52 6.9k 1.1× 3.0k 0.7× 2.7k 0.6× 2.2k 0.6× 979 0.3× 332 10.3k
Ezio Bonifacio Germany 78 12.2k 1.9× 13.9k 3.2× 10.8k 2.5× 2.3k 0.6× 3.6k 1.0× 354 20.4k
Flemming Pociot Denmark 61 5.2k 0.8× 7.2k 1.7× 3.9k 0.9× 4.6k 1.1× 4.5k 1.2× 326 16.2k
Äkïhïko Okuyama Japan 50 1.9k 0.3× 1.4k 0.3× 1.0k 0.2× 3.3k 0.8× 789 0.2× 479 9.4k
Phillip Ruiz United States 54 3.5k 0.6× 634 0.1× 841 0.2× 1.9k 0.5× 2.4k 0.6× 297 11.1k
Christine Sempoux Belgium 52 4.4k 0.7× 919 0.2× 1.6k 0.4× 1.8k 0.4× 539 0.1× 314 9.9k
Anthony J. Demetris United States 81 11.0k 1.7× 1.1k 0.3× 416 0.1× 3.4k 0.8× 3.7k 1.0× 379 23.3k
Noriko Murase United States 66 7.8k 1.2× 1.4k 0.3× 211 0.0× 4.0k 1.0× 2.9k 0.8× 282 15.2k

Countries citing papers authored by David M. Harlan

Since Specialization
Citations

This map shows the geographic impact of David M. Harlan's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by David M. Harlan with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites David M. Harlan more than expected).

Fields of papers citing papers by David M. Harlan

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by David M. Harlan. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by David M. Harlan. The network helps show where David M. Harlan may publish in the future.

Co-authorship network of co-authors of David M. Harlan

This figure shows the co-authorship network connecting the top 25 collaborators of David M. Harlan. A scholar is included among the top collaborators of David M. Harlan based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with David M. Harlan. David M. Harlan is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
2.
Haliyur, Rachana, John T. Walker, May Sanyoura, et al.. (2021). Integrated Analysis of the Pancreas and Islets Reveals Unexpected Findings in Human Male With Type 1 Diabetes. Journal of the Endocrine Society. 5(12). bvab162–bvab162. 1 indexed citations
3.
Marré, Meghan L., John W. McGinty, I‐Ting Chow, et al.. (2018). Modifying Enzymes Are Elicited by ER Stress, Generating Epitopes That Are Selectively Recognized by CD4+ T Cells in Patients With Type 1 Diabetes. Diabetes. 67(7). 1356–1368. 67 indexed citations
4.
Walsh, Nicole C., Ken‐Edwin Aryee, Agata Jurczyk, et al.. (2017). Possible type 1 diabetes risk prediction: Using ultrasound imaging to assess pancreas inflammation in the inducible autoimmune diabetes BBDR model. PLoS ONE. 12(6). e0178641–e0178641. 8 indexed citations
5.
Delong, Thomas, Timothy A. Wiles, Rocky L. Baker, et al.. (2016). Pathogenic CD4 T cells in type 1 diabetes recognize epitopes formed by peptide fusion. Science. 351(6274). 711–714. 379 indexed citations breakdown →
6.
Derr, Alan, Chaoxing Yang, Rapolas Žilionis, et al.. (2016). End Sequence Analysis Toolkit (ESAT) expands the extractable information from single-cell RNA-seq data. Genome Research. 26(10). 1397–1410. 33 indexed citations
7.
Harlan, David M., et al.. (2013). Diabetes: 8 strategies to put into practice.. PubMed. 62(10). 542–7. 5 indexed citations
8.
Greiner, Dale L., Michael A. Brehm, Vishnu Hosur, et al.. (2011). Humanized mice for the study of type 1 and type 2 diabetes. Annals of the New York Academy of Sciences. 1245(1). 55–58. 26 indexed citations
9.
Giovannucci, Edward L., David M. Harlan, Michael C. Archer, et al.. (2010). Diabetes and Cancer. Diabetes Care. 33(7). 1674–1685. 1753 indexed citations breakdown →
10.
Pechhold, Klaus, Kerstin Koczwara, Xiaolong Zhu, et al.. (2009). Blood Glucose Levels Regulate Pancreatic β-Cell Proliferation during Experimentally-Induced and Spontaneous Autoimmune Diabetes in Mice. PLoS ONE. 4(3). e4827–e4827. 35 indexed citations
11.
Rother, Kristina I. & David M. Harlan. (2004). Challenges facing islet transplantation for the treatment of type 1 diabetes mellitus. Journal of Clinical Investigation. 114(7). 877–883. 146 indexed citations
12.
Rother, Kristina I. & David M. Harlan. (2004). Challenges facing islet transplantation for the treatment of type 1 diabetes mellitus. Journal of Clinical Investigation. 114(7). 877–883. 144 indexed citations
13.
Louis, Daniel C. St., Juliana B. Woodcock, Patrick J. Blair, et al.. (2004). Evidence for Distinct Intracellular Signaling Pathways in CD34+ Progenitor to Dendritic Cell Differentiation from a Human Cell Line Model. The Journal of Immunology. 173(10). 6490–6490. 67 indexed citations
14.
Xu, He, Sean P. Montgomery, Douglas K. Tadaki, et al.. (2003). Studies Investigating Pretransplant Donor-Specific Blood Transfusion, Rapamycin, and the CD154-Specific Antibody IDEC-131 in a Nonhuman Primate Model of Skin Allotransplantation. The Journal of Immunology. 170(5). 2776–2782. 54 indexed citations
15.
Montgomery, Sean P., Steven Mog, He Xu, et al.. (2002). Efficacy and Toxicity of a Protocol Using Sirolimus, Tacrolimus and Daclizumab in a Nonhuman Primate Renal Allotransplant Model. American Journal of Transplantation. 2(4). 381–385. 28 indexed citations
16.
Xu, He, Douglas K. Tadaki, Eric A. Elster, et al.. (2002). Humanized anti-CD154 antibody therapy for the treatment of allograft rejection in nonhuman primates. Transplantation. 74(7). 940–943. 29 indexed citations
17.
Hoffmann, Steven C., Elizabeth Cox, Deloris E. Koziol, et al.. (2002). Ethnicity Greatly Influences Cytokine Gene Polymorphism Distribution. American Journal of Transplantation. 2(6). 560–567. 279 indexed citations
18.
Pechhold, Klaus, Noelle B. Patterson, Carmen Blum, et al.. (2001). Low Dose Streptozotocin-Induced Diabetes in Rat Insulin Promoter-mCD80-Transgenic Mice Is T Cell Autoantigen-Specific and CD28 Dependent. The Journal of Immunology. 166(4). 2531–2539. 28 indexed citations
19.
Elster, Eric A., He Xu, Douglas K. Tadaki, et al.. (2001). Primate skin allotransplantation with anti-CD154 monotherapy. Transplantation Proceedings. 33(1-2). 675–676. 15 indexed citations
20.
Herrera, Pedro L., David M. Harlan, Liliane Fossati, et al.. (1994). A CD8+ T-lymphocyte-mediated and CD4+ T-lymphocyte-independent autoimmune diabetes of early onset in transgenic mice. Diabetologia. 37(12). 1277–1279. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026